ATRO Stock Analysis: Astronics | NASDAQ
Aerospace & Defense | NASDAQ, USA | Market Cap: 3.495m USD | 12M Return: 192.2% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 67.7M
Qual. Beats: -1
Rev. Trend: -5.8%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Astronics Corporation (NASDAQ: ATRO) is a U.S.-based supplier that designs and manufactures specialized products for the aerospace, defense, and electronics industries, operating across the United States, North America, Asia, Europe, and South America. The company runs two segments: Aerospace, which provides lighting, safety, power generation, distribution, seat motion, structures, and avionics products to aircraft OEMs, airlines, and the U.S. Department of Defense; and Test Systems, which builds automated test equipment and training/simulation devices for aerospace, defense, communications, and mass transit customers.
As a tier-1 supplier in the Aerospace & Defense sector, Astronics typically operates within long product certification cycles tied to airframe programs, with revenue concentrated among a small number of commercial and military OEMs. The company was incorporated in 1968, is headquartered in East Aurora, New York, and has been listed on NASDAQ since 1984. It is classified as a mid-cap stock within the GICS Industrials sector, Aerospace & Defense sub-industry.
- Boeing and Airbus production rate increases boost Aerospace revenue
- Defense avionics and military lighting demand supports margins
- Test Systems segment revenue pressured by program timing and customer mix
| Net Income: 45.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.76 > 1.0 |
| NWC/Revenue: 35.06% < 20% (prev 33.65%; Δ 1.41% < -1%) |
| CFO/TA 0.09 > 3% & CFO 65.5m > Net Income 45.4m |
| Net Debt (411.5m) to EBITDA (80.4m): 5.11 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.2m) vs 12m ago -11.02% < -2% |
| Gross Margin: 30.72% > 18% (prev 25.63%; Δ 5.09% > 0.5%) |
| Asset Turnover: 125.8% > 50% (prev 123.3%; Δ 2.58% > 0%) |
| Interest Coverage Ratio: 4.96 > 6 (EBIT TTM 58.3m / Interest Expense TTM 11.7m) |
| A: 0.42 (Total Current Assets 468.6m - Total Current Liabilities 157.7m) / Total Assets 747.1m |
| B: 0.32 (Retained Earnings 242.2m / Total Assets 747.1m) |
| C: 0.08 (EBIT TTM 58.3m / Avg Total Assets 704.7m) |
| D: 0.28 (Book Value of Equity 161.7m / Total Liabilities 585.4m) |
| Altman-Z'' = 4.63 = AA |
| DSRI: 1.03 (Receivables 217.0m/194.0m, Revenue 886.8m/816.3m) |
| GMI: 0.83 (GM 25.63% / 30.72%) |
| AQI: 1.00 (AQ_t 0.17 / AQ_t-1 0.17) |
| SGI: 1.09 (Revenue 886.8m / 816.3m) |
| TATA: -0.03 (NI 45.4m - CFO 65.5m) / TA 747.1m) |
| Beneish M = -3.09 (Cap -4..+1) = AA |
As of July 12, 2026, the stock is trading at USD 72.50 with a total of 872,309 shares traded. Over the past week, the price has changed by +2.36%, over one month by +10.33%, over three months by +25.32% and over the past year by +192.19%.
Current recommended Stop Loss: 67.10 (which is 7.4% or 1.1 ATR below the current price).
Astronics has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold ATRO.
- StrongBuy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 76.2 | 5% |
P/E Trailing = 70.1287
P/E Forward = 27.1739
P/S = 3.9415
P/B = 21.6312
P/EG = 1.4507
Revenue TTM = 886.8m USD
EBIT TTM = 58.3m USD
EBITDA TTM = 80.4m USD
Long Term Debt = 334.9m USD (from longTermDebt, last quarter)
Short Term Debt = 5.99m USD (from shortTermDebt, last quarter)
Debt = 423.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 44.2m
Net Debt = 411.5m USD (calculated: Debt 423.3m - CCE 11.9m)
Enterprise Value = 3.91b USD (3.50b + Debt 423.3m - CCE 11.9m)
Interest Coverage Ratio = 4.96 (Ebit TTM 58.3m / Interest Expense TTM 11.7m)
EV/FCF = 157.7x (Enterprise Value 3.91b / FCF TTM 24.8m)
FCF Yield = 0.63% (FCF TTM 24.8m / Enterprise Value 3.91b)
FCF Margin = 2.79% (FCF TTM 24.8m / Revenue TTM 886.8m)
Net Margin = 5.12% (Net Income TTM 45.4m / Revenue TTM 886.8m)
Gross Margin = 30.72% ((Revenue TTM 886.8m - Cost of Revenue TTM 614.4m) / Revenue TTM)
Gross Margin QoQ = 32.58% (prev 33.31%)
Tobins Q-Ratio = 5.23 (Enterprise Value 3.91b / Total Assets 747.1m)
Interest Expense / Debt = 2.77% (Interest Expense 11.7m / Debt 423.3m)
Taxrate = 2.55% (1.19m / 46.6m)
NOPAT = 56.8m (EBIT 58.3m * (1 - 2.55%))
Current Ratio = 2.97 (Total Current Assets 468.6m / Total Current Liabilities 157.7m)
Debt / Equity = 2.62 (Debt 423.3m / totalStockholderEquity, last quarter 161.7m)
Debt / EBITDA = 5.11 (Net Debt 411.5m / EBITDA 80.4m)
Debt / FCF = 16.61 (Net Debt 411.5m / FCF TTM 24.8m)
Total Stockholder Equity = 170.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.44% (Net Income 45.4m / Total Assets 747.1m)
RoE = 26.60% (Net Income TTM 45.4m / Total Stockholder Equity 170.6m)
RoCE = 11.53% (EBIT 58.3m / Capital Employed (Equity 170.6m + L.T.Debt 334.9m))
RoIC = 9.74% (NOPAT 56.8m / Invested Capital 583.6m)
WACC = 9.27% (E(3.50b)/V(3.92b) * Re(10.06%) + D(423.3m)/V(3.92b) * Rd(2.77%) * (1-Tc(0.03)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 46.67 | Cagr: 4.15%
[DCF] Terminal Value 69.74% ; FCFF base≈31.0m ; Y1≈27.1m ; Y5≈21.9m
[DCF] Fair Price = N/A (negative equity: EV 305.9m - Net Debt 411.5m = -105.5m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.99 | # QB: -1
Revenue Correlation: -5.79 | Revenue CAGR: -0.99% | SUE: 0.44 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.56 | Chg30d=+5.08% | Revisions=+57% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.59 | Chg30d=+3.28% | Revisions=+29% | Analysts=4
EPS current Year (2026-12-31): EPS=2.26 | Chg30d=+2.55% | Revisions=+50% | GrowthEPS=+34.8% | GrowthRev=+14.6%
EPS next Year (2027-12-31): EPS=2.60 | Chg30d=-0.56% | Revisions=+17% | GrowthEPS=+15.3% | GrowthRev=+7.8%
[Analyst] Revisions Ratio: +59% (up=12, down=2)